Capricor Therapeutics Inc (NASDAQ:CAPR)
| 4.17 BATS BZX Real-Time Price As of 1:09pm ET |  +0.09 / +2.21%Today’s Change | 2.81 Today|||52-Week Range 6.58 | +8.03% Year-to-Date |
Latest CAPR News | Press Releases
No recent news for Capricor Therapeutics Inc.
Today’s Trading
| Previous close | 4.08 |
| Today’s open | 4.14 |
| Day’s range | 4.14 - 4.20 |
| Volume | 61 |
| Average volume (3 months) | 139,872 |
| Market cap | $105.0M |
Data as of 1:09pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | +1.13% |
| Earnings growth (this year) | -39.85% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -21.06% |
| P/E ratio | NM |
| Price/Sales | 276.24 |
| Price/Book | 3.21 |
Competitors
Data as of 1:21pm ET, 02/08/2023
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $244.9K |
| Annual profit (last year) | -$20.0M |
| Net profit margin | -8,175.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
